Capecitabine 500mg
$489.50 – $1602.00

| Product name | Letrozol 2.5mg |
|---|---|
| Active Ingredient | Letrozol |
| Dosage | 2.5mg |
| Drug Type | Tablets |
| Indication | Breast Cancer |
| Manufacturer | Cipla Limited |
Total $25.80
Letrozole 2.5mg is a prescription medicine mainly used in the treatment of hormone-sensitive breast cancer in women.
It belongs to a group of medicines called aromatase inhibitors. These medicines work by lowering estrogen levels in the body.
Estrogen is a natural female hormone. In some types of breast cancer, estrogen can help cancer cells grow faster.
Doctors such as oncologists prescribe Letrozole 2.5mg tablets as part of long-term cancer treatment plans.
This medicine is usually used after menopause, when the body no longer produces large amounts of estrogen from the ovaries.
After taking Letrozole 2.5mg, the medicine works by reducing the amount of estrogen in the body.
The body produces estrogen using an enzyme called aromatase.
Letrozole blocks this enzyme.
When aromatase is blocked, estrogen production becomes very low.
This helps slow down or stop the growth of hormone-sensitive breast cancer cells.
Cancer cells that depend on estrogen cannot grow properly when estrogen levels are reduced.
Over time, this helps control the spread of cancer and supports treatment success.
Doctors carefully monitor hormone levels and treatment response during therapy.
Doctors prescribe Letrozole 2.5mg mainly for hormone receptor-positive breast cancer in postmenopausal women.
It is used to treat early-stage breast cancer after surgery to reduce the risk of cancer coming back.
It is also used in advanced or metastatic breast cancer, where the disease has spread to other parts of the body.
In some cases, it is used when other hormone therapies are not effective.
Letrozole is an important part of long-term cancer control therapy.
It is not a chemotherapy drug, but a hormonal therapy medicine.
Doctors decide treatment duration based on cancer stage and patient response.
Letrozole works by blocking estrogen production in the body.
Estrogen is made in small amounts in fat tissue and other parts of the body through the aromatase enzyme.
Letrozole blocks this enzyme completely or almost completely.
When estrogen levels drop, hormone-sensitive breast cancer cells lose their growth signal.
Without estrogen, these cancer cells grow more slowly or stop growing.
This helps control disease progression and reduces the chance of cancer returning.
The medicine works slowly over time and is used as long-term therapy.
Oncologists regularly monitor the patient’s condition during treatment.
Like all medicines, Letrozole 2.5mg may cause side effects in some patients.
Common side effects include:
hot flashes, joint pain, muscle pain, fatigue, sweating, and headache.
Some women may feel stiffness in joints or mild bone discomfort.
Loss of bone strength (bone thinning) may occur with long-term use because of low estrogen levels.
Less common side effects include:
nausea, dizziness, weight changes, or mood changes.
Rare but serious side effects include:
bone fractures, high cholesterol levels, or severe weakness.
Doctors may recommend calcium and vitamin D support and bone monitoring during treatment.
Patients should report persistent pain or unusual symptoms to their doctor.
This content is for educational purposes only. It does not replace medical advice, diagnosis, or treatment. Always consult an oncologist or healthcare professional before using Letrozole 2.5mg. Use this medicine only as prescribed and follow regular monitoring during cancer therapy.